Close
Close
Home - - Recivit® returns to Ethypharm’s portfolio in France

Do you have
any question?

Contact us
06/05/2025

Recivit® returns to Ethypharm’s portfolio in France

As of April 2025, Ethypharm has taken back the distribution in France for Recivit® (fentanyl), a treatment used in the management of severe pain.

Previously distributed by Grünenthal, Recivit® is now reintegrated into the French portfolio, reinforcing Ethypharm’s longstanding experience and comprehensive approach to pain treatment.

This development further demonstrates our strong commitment to bringing therapeutic solutions to patients affected by pain.

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.